ISRG's Vessel Sealer Curved for da Vinci Systems Gets FDA Approval

Company Overview - Intuitive Surgical (ISRG) received FDA clearance for its Vessel Sealer Curved, a multifunctional instrument for da Vinci surgical systems, enhancing procedural efficiency in minimally invasive surgeries [2][5] - The Vessel Sealer Curved integrates advanced bipolar energy technology with refined mechanical design, improving performance and precision in robotic-assisted surgeries [3][9] - The new instrument can grasp, dissect, coagulate, and transect tissue, increasing procedural efficiency and broadening the appeal of robotic-assisted surgery across specialties [5][10] Financial Performance - ISRG has a market capitalization of $183.59 billion and an earnings yield of 1.45%, which is higher than the industry's negative 2.88% [6] - In the last reported quarter, ISRG delivered an earnings surprise of 5.85% [6] Stock Performance - Following the FDA clearance announcement, ISRG shares traded flat, with a year-to-date loss of 1.8%, compared to the industry's 11.5% decline and the S&P 500's gain of 5.6% [4] Industry Prospects - The global surgical robots market is projected to grow from $4.31 billion in 2024 to $7.42 billion by 2030, with a CAGR of 9.42% from 2025 to 2030, driven by technological innovation and increasing investments [13]